Citation Impact

Citing Papers

CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity
2010 StandoutNobel
Characterization of chemical ingredients and anticonvulsant activity of American skullcap (Scutellaria lateriflora)
2008
Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets
2014
SH-SY5Y neuroblastoma cells: a model system for studying biosynthesis of NAAG
2004
The FGF family: biology, pathophysiology and therapy
2009 Standout
Synthesis and release of N-acetylaspartylglutamate (NAAG) by crayfish nerve fibers: implications for axon–glia signaling
2001
Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species
2013 Standout
The ketogenic diet: metabolic influences on brain excitability and epilepsy
2012
Glutamate‐like Immunoreactivity in Retinal Terminals of the Mouse Suprachiasmatic Nucleus
1993
N‐acetylaspartylglutamate immunoreactivity in neurons of the monkey's visual pathway
1991
Signaling by insulin-like growth factor 1 in brain
2004
N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology
2007 Standout
N-acetylaspartylglutamate immunoreactivity in human retina
1996
Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain
1995
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Hepatic Fibroblast Growth Factor 21 Is Regulated by PPARα and Is a Key Mediator of Hepatic Lipid Metabolism in Ketotic States
2007
Peptide therapeutics: current status and future directions
2014 Standout
Chronic Back Pain Is Associated with Decreased Prefrontal and Thalamic Gray Matter Density
2004 Standout
N-Acetylaspartylglutamate catabolism is achieved by an enzyme on the cell surface of neurons and glia
1993
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
2009 Standout
Energy Metabolism in the Liver
2014 Standout
Neurodegenerative diseases and oxidative stress
2004 Standout
Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders
2003
N‐Acetylaspartylglutamate
2000
Uptake, Metabolism, and Release of N‐[3H]‐Acetylaspartylglutamate by the Avian Retina
1992
Expression of N-Acetylaspartate and N-Acetylaspartylglutamate in the Nervous System
2006
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease
2015 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Cerebral Metabolic Adaptation and Ketone Metabolism after Brain Injury
2007
Spermidine in health and disease
2018 StandoutScience
The genus Scutellaria an ethnopharmacological and phytochemical review
2010 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
The Mammalian Circadian Timing System: Organization and Coordination of Central and Peripheral Clocks
2010 Standout
Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake
2003

Works of Douglas A. Eagles being referenced

A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion
2000
Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet
1999
Localization and Synaptic Release of N‐acetylaspartyl‐glutamate in the Chick Retina and Optic Tectum
1991
Higher ketogenic diet ratios confer protection from seizures without neurotoxicity
1999
A Ketogenic Diet Increases the Resistance to Pentylenetetrazole‐Induced Seizures in the Rat
1999
Path Analysis Shows That Increasing Ketogenic Ratio, but Not β-Hydroxybutyrate, Elevates Seizure Threshold in the Rat
1999
An anticonvulsant profile of the ketogenic diet in the rat
2002
A Ketogenic Diet Increases Brain Insulin-Like Growth Factor Receptor and Glucose Transporter Gene Expression
2003
Rankless by CCL
2026